| Filed On | Filing |
|---|---|
| 04 Aug 2026 |
Form 4: Uihlein Richard E, Director
Received 34,376,167 shares by exercise or conversion ($106M) |
| 16 Jul 2026 |
Form 4: Jamil Khurram, Chief Medical Officer
Received 16,250 shares by exercise or conversion ($49.4K) · Sold 16,250 shares ($83.3K) |
| 30 Jun 2026 |
Form 4: Shlevin Harold H., Director
Received 7,732 shares by exercise or conversion ($9.51K) · Sold 7,732 shares ($38.7K) · Received 22,268 shares by exercise or conversion ($27.4K) · 1 more |
| 30 Jun 2026 |
Form 4: Jamil Khurram, Chief Medical Officer
Received 4,570 shares by exercise or conversion ($10.8K) · Sold 4,570 shares ($22.9K) · Received 47,467 shares by exercise or conversion ($119K) · 1 more |
| 25 Jun 2026 |
Form 4: Jamil Khurram, Chief Medical Officer
Received 7,557 shares by exercise or conversion ($9.3K) · Sold 7,557 shares ($23.7K) |
| 28 May 2026 |
Form 4: Jamil Khurram, Chief Medical Officer
Received 568 shares by exercise or conversion ($699) · Sold 568 shares ($1.76K) |
| 17 Mar 2026 |
Form 4: Brem Henry, Director
Granted 60,000 Stock option (right to buy) |
| 09 Feb 2026 |
Form 4: Eldred Kary, Director
Bought 300 shares ($810) |
| 21 Jan 2026 |
Form 4: Carson Benjamin Sr, Director
Granted 60,000 Stock option (right to buy) |
| 21 Jan 2026 |
Form 4: Zordani Richard A. Jr., Director
Granted 60,000 Stock option (right to buy) |
| 21 Jan 2026 |
Form 4: Jamil Khurram, Chief Medical Officer
Granted 65,000 Stock option (right to buy) · Granted 100,000 Restricted Stock Unit |
| 21 Jan 2026 |
Form 4: Freeman Kevin D, Director
Granted 60,000 Stock option (right to buy) |
| 21 Jan 2026 |
Form 4: Eldred Kary, Director
Granted 60,000 Stock option (right to buy) |
| 21 Jan 2026 |
Form 4: Lewis Joel, Director
Granted 84,000 Stock option (right to buy) · Granted 120,000 Restricted Stock Unit |
| 21 Jan 2026 |
Form 4: Callicutt Jack W, Chief Financial Officer
Granted 65,000 Stock option (right to buy) · Granted 100,000 Restricted Stock Unit |
| 21 Jan 2026 |
Form 4: Shlevin Harold H., Director
Granted 60,000 Stock option (right to buy) |
| 21 Jan 2026 |
Form 4: Omenn Gilbert S, Director
Granted 60,000 Stock option (right to buy) |
| 21 Jan 2026 |
Form 4: Amelio Gilbert F, Director
Granted 60,000 Stock option (right to buy) |
| 21 Jan 2026 |
Form 4: Schwartz Elissa J., Director
Granted 60,000 Stock option (right to buy) |
| 21 Jan 2026 |
Form 4: Uihlein Richard E, Director
Received 13,158 shares as a grant or award ($40K) · Granted 60,000 Stock option (right to buy) |
Loading...